FDA warns on Zerbaxa dosing errors; Merck KGaA chief repeats pharma-growth pledge; Takeda inks flu-shot marketing deal;

@FiercePharma: Bionic turtle offers glimpse into future of 3-D printing. FierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: ICYMI from FiercePharmaManufacturing: FDA blesses Baxter saline plant in Spain for shipments to U.S. of 0.9% sodium chloride. Article | Follow @EricPFierce

@CarlyHFierce: ICYMI: Want the U.K.'s NHS to quickly adopt new products, drugmakers? There's an office for that. Item | Follow @CarlyHFierce

> The FDA warned doctors about the risk of dosing errors with Merck & Co.'s ($MRK) new high-powered combination antibiotic, Zerbaxa (ceftolozane/tazobactam), acquired with Cubist earlier this year. Report

> In an interview with the weekly publication Euro am Sonntag, Merck KGaA CEO Karl-Ludwig Kley once again pledged that the German company's pharma division would fuel overall revenue growth of about 5%. Report

> China's Jiuzhitang nabbed Beijing Youbo Pharmaceutical in a stock-based deal worth $1 billion. Report

> Japan's Takeda inked a deal to market a seasonal flu vaccine from Kaketsuken in Japan. Report

> Abbott Laboratories ($ABT) said it would offer a "non-GMO" version of its infant formula Similac Advance. Report

Medical Device News

@FierceMedDev: ICYMI: Sequenom stares down suit from Indian genomics firm. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: ICYMI: NIH announces winning teams of Neuro Startup Challenge to commercialize its inventions. Report | Follow @VarunSaxena2

@EmilyWFierce: Study: Gilead's Harvoni could save U.S. and Europe billions in worker productivity. More from FiercePharma | Follow @EmilyWFierce

> SI-Bone raises $21M, brings on new CFO to grow iFuse implant sales. More

> Strong data from Medtronic's latest TAVR caps excellent week for the devices at European conference. Report

Biotech News

@FierceBiotech: The FierceBiotech panel: Top research execs tackle the fast-changing field of cancer drug R&D at BIO 2015. More | Follow @FierceBiotech

@JohnCFierce: This should be interesting: Can PureTech and its high-profile board raise $160M in London? More | Follow @JohnCFierce

> Sanofi buys into NeuroVive's cardio drug in Korea. Item

> Boehringer snags FDA approval for COPD combo drug. Article

> Amicus' rare disease drug lines up for a quick EU approval. Story

> Suicide stunner prompts Amgen to dump brodalumab and its AstraZeneca deal. Report

Pharma Manufacturing News

> Law enforcement makes another illegal pharma supply chain bust; 2nd in U.S. in 8 days. More

> Singapore moving to meet pharma manufacturing demand for high-quality water. Report

> Strides Arcolab pays $287M for Aspen Pharmacare's Australian business. Article

> Report: Russia quickly becoming a major source of online fake pharma. Item

> Cipla pulls levalbuterol on FDA warning; Wockhardt removes other drugs on concerns. Story

Animal Health News

> Wal-Mart hailed for leadership on animal welfare. Story

> Animal health, production in St. Joseph, MO, ranks fourth in U.S. metro ag economies. Report

> Patterson posts record quarterly results amid shift toward animal health. Story

> Bionic turtle offers glimpse into future of 3-D printing. Item

> Chicken producer Sanderson says FDA's crackdown on antibiotics lacks 'reliable science.' Article

Biotech IT News

> PatientsLikeMe nabs Merck informatics veteran to lead R&D. More

> Gentleman aims to use 23andMe's R&D blank slate to tip in vivo-in silico testing balance. Story

> Trialbee raises $5M to mount U.S. expansion of online trial enrollment business. Item

> Celgene taps Cypher Genomics to spot biomarkers in datasets. Article

> Hedge fund aims algorithms at pharma patents to sink stocks. Report

Drug Delivery News

> Nanoparticles tagged with amino acids help diagnose glioblastoma to someday target drugs. News

> Pacira's liposomal-encased bupivacaine gets positive reviews at breast cancer conference. Report

> European researchers developing implantable, insulin-controlling capsule to fight diabetes. More

> FDA approves long-acting formulation of J&J schizophrenia med. Item

> Data-gathering insulin pen maker Companion pulls in Series B led by Eli Lilly. Article

Pharma Asia News

> Australia zeroes in on pharma in transfer-pricing probe. News

> Heavyweight Chinese consortium buys San Diego-based Ambrx. Article

> Pakistan seen as hot pharma growth market. Story

> CBMG says China and U.S. growing quickly closer in biotech space. More

> China Medical Systems in Greater China deal with Finland's Faron on respiratory candidate. Article

And Finally... A map identifying "distinctive" causes of death in the 50 U.S. states has gone viral. Report

Suggested Articles

AbbVie has seen blossoming market share for immunology launches Rinvoq and Skyrizi—and it's eyeing Allergan's neurology biz for a boost, too.

While Novo's Rybelsus launch has slowed due to the pandemic, another version of the med, Ozempic posted strong sales.

AZ sold Atacand and Atacand Plus rights in about 70 countries to Cheplapharm.